Shopping Cart
Remove All
Your shopping cart is currently empty
Glembatumumab, CY3 labeled is a humanized antibody targeting the extracellular domain of GPNMB, with potential antitumor activity, used in studies of triple-negative breast cancer.

| Description | Glembatumumab, CY3 labeled is a humanized antibody targeting the extracellular domain of GPNMB, with potential antitumor activity, used in studies of triple-negative breast cancer. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Storage | keep away from direct sunlight | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.